Related Experiment Video

Updated: Aug 20, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

Signal transduction pathways as novel therapy targets in lung cancer

Niels Reinmuth1, Rolf M Mesters, Ralf Bieker

  • 1Department of Medicine/Hematology, Oncology and Respiratory Medicine, University of Muenster, Albert-Schweitzer-Str. 33, D-48129 Muenster, Germany. reinmut@uni-muenster.de

Lung Cancer (Amsterdam, Netherlands)
|November 24, 2004
PubMed

Insights

Lung cancer treatment remains challenging. This review explores key molecular signaling pathways and novel targeted therapies for lung cancer, offering new hope for patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer treatment has seen limited progress with traditional cytotoxic therapies.
  • Intensive research has elucidated the molecular underpinnings of lung cancer, including genetic alterations and environmental influences.
  • Cancer cell behavior is significantly impacted by external factors through receptor-mediated signaling pathways.

Purpose of the Study:

  • To review essential receptors and signaling pathways implicated in lung cancer development and progression.
  • To discuss emerging targeted therapies that specifically act on these molecular pathways.
  • To highlight novel agents that have advanced to clinical trials for lung cancer treatment.

Main Methods:

  • Literature review of current research on lung cancer molecular biology.
  • Analysis of key signaling pathways involved in lung cancer pathogenesis.
  • Survey of targeted therapeutic agents and their clinical trial status.

Main Results:

  • Identification of critical receptors and signaling cascades driving lung cancer.
  • Examples of targeted agents demonstrating potential in preclinical and clinical settings.
  • Discussion of the therapeutic strategies based on molecular pathway inhibition.

Conclusions:

  • Understanding lung cancer molecular signaling is crucial for developing effective treatments.
  • Targeted therapies offer a promising avenue to overcome limitations of conventional chemotherapy.
  • Ongoing research and clinical trials are vital for advancing lung cancer patient care.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...